AllianceBernstein’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$441K Buy
180,140
+60,675
+51% +$149K ﹤0.01% 2717
2025
Q1
$797K Buy
119,465
+45,705
+62% +$305K ﹤0.01% 2348
2024
Q4
$927K Sell
73,760
-217,346
-75% -$2.73M ﹤0.01% 2372
2024
Q3
$5.38M Buy
291,106
+29,759
+11% +$550K ﹤0.01% 1490
2024
Q2
$5.63M Buy
261,347
+106,103
+68% +$2.28M ﹤0.01% 1444
2024
Q1
$4.18M Buy
155,244
+78,734
+103% +$2.12M ﹤0.01% 1536
2023
Q4
$2.29M Sell
76,510
-50,092
-40% -$1.5M ﹤0.01% 1864
2023
Q3
$2.59M Buy
126,602
+2,692
+2% +$55.2K ﹤0.01% 1732
2023
Q2
$2.46M Sell
123,910
-51,111
-29% -$1.02M ﹤0.01% 1788
2023
Q1
$3M Buy
175,021
+126,121
+258% +$2.16M ﹤0.01% 1649
2022
Q4
$957K Hold
48,900
﹤0.01% 2304
2022
Q3
$780K Sell
48,900
-115,989
-70% -$1.85M ﹤0.01% 2418
2022
Q2
$2.27M Buy
164,889
+40,989
+33% +$564K ﹤0.01% 1876
2022
Q1
$1.97M Sell
123,900
-19,912
-14% -$316K ﹤0.01% 2091
2021
Q4
$3.14M Sell
143,812
-4,460
-3% -$97.3K ﹤0.01% 1865
2021
Q3
$4.43M Buy
148,272
+93,425
+170% +$2.79M ﹤0.01% 1668
2021
Q2
$2.43M Buy
54,847
+6,047
+12% +$268K ﹤0.01% 2062
2021
Q1
$2.17M Buy
48,800
+800
+2% +$35.5K ﹤0.01% 2044
2020
Q4
$2.63M Buy
48,000
+13,000
+37% +$713K ﹤0.01% 1812
2020
Q3
$800K Sell
35,000
-1,400
-4% -$32K ﹤0.01% 2276
2020
Q2
$762K Buy
36,400
+1,400
+4% +$29.3K ﹤0.01% 2344
2020
Q1
$488K Sell
35,000
-2,400
-6% -$33.5K ﹤0.01% 2361
2019
Q4
$851K Sell
37,400
-3,900
-9% -$88.7K ﹤0.01% 2336
2019
Q3
$481K Buy
41,300
+10,500
+34% +$122K ﹤0.01% 2560
2019
Q2
$462K Buy
30,800
+6,600
+27% +$99K ﹤0.01% 2632
2019
Q1
$424K Buy
24,200
+4,000
+20% +$70.1K ﹤0.01% 2588
2018
Q4
$299K Buy
20,200
+5,100
+34% +$75.5K ﹤0.01% 2726
2018
Q3
$372K Sell
15,100
-44,800
-75% -$1.1M ﹤0.01% 2740
2018
Q2
$1.18M Buy
+59,900
New +$1.18M ﹤0.01% 2221
2015
Q3
Sell
-97,990
Closed -$1.92M 2976
2015
Q2
$1.92M Buy
97,990
+46,995
+92% +$921K ﹤0.01% 1825
2015
Q1
$1.11M Buy
+50,995
New +$1.11M ﹤0.01% 2124